Knowledge to Impact - By Wiley Medical Education

Part 7: Early Recognition and Intervention in Cancer Cachexia

Welcome to our second Patient Case Study on cancer cachexia. Cancer cachexia is a progressive muscle-wasting syndrome that significantly diminishes the quality of life for many patients with cancer. For this episode, we are again joined by Associate Professor Richard Dunne who discusses the case study of a patient with cancer cachexia, highlighting challenges in treatment strategies and interventions. The episode offers practical recommendations for managing unintentional weight loss, changes in bowel habits, anemia, and improving quality of life in patients with cancer cachexia.  This discussion was originally broadcast as a Video Clinical Case Study, published as part of the American Cancer Society - Cancer Cachexia Knowledge Hub educational program. To view the original video please visit https://cancercachexia.knowledgehub.wiley.com/case-studies/ [https://cancercachexia.knowledgehub.wiley.com/case-studies/]. The Knowledge Hub also contains additional educational materials on cancer cachexia, including two ACCME accredited webinar broadcasts, conference highlights from AACR 2025, ASCO 2025, ASCO GI 2026, ESMO 2025, SCWD 2024 and 2025 as well as additional resources such as research article collections and downloadable infographics.  The Cancer Cachexia Knowledge Hub program is supported by an educational grant from Pfizer.  Speaker – Dr Richard Dunne. Associate Professor of Medicine & Section Leader, GI Oncology, Wilmot Cancer Institute and The University of Rochester Medical Center. Full speaker biography - https://cancercachexia.knowledgehub.wiley.com/faculty/ [https://cancercachexia.knowledgehub.wiley.com/faculty/]   For more medical education from Wiley, please visit https://focus.wiley.com/ [https://focus.wiley.com/]

Part 6: Early Recognition and Intervention in Cancer Cachexia

Welcome to the second part of our Cancer Cachexia ASCO 2025 Highlights. Cancer cachexia is a progressive muscle-wasting syndrome that significantly diminishes the quality of life for many patients with cancer. For the second installment we are joined by Professor Jeffrey Crawford who will be sharing his highlights from ASCO 2025, specifically looking at key highlights on emerging therapeutic agents for cancer cachexia including the hypothesis guiding drug development, pioneering clinical trials, and their results.  This discussion was originally broadcast as a Conference Highlights Video, published as part of the American Cancer Society - Cancer Cachexia Knowledge Hub educational program. To view the original video please visit https://cancercachexia.knowledgehub.wiley.com/conference-coverage/asco-2025-highlights/ [https://cancercachexia.knowledgehub.wiley.com/conference-coverage/asco-2025-highlights/]. The Knowledge Hub also contains additional educational materials on cancer cachexia, including two ACCME accredited webinar broadcasts, conference highlights from AACR 2025, ASCO 2025, ASCO GI 2026, ESMO 2025, SCWD 2024 and 2025 as well as additional resources such as research article collections and downloadable infographics.  The Cancer Cachexia Knowledge Hub program is supported by an educational grant from Pfizer.  Speaker – Professor Jeffrey Crawford. George Barth Galler Professor for Research in Cancer, Department of Medicine, Duke University Medical Center. Full speaker biography - https://cancercachexia.knowledgehub.wiley.com/faculty/ [https://cancercachexia.knowledgehub.wiley.com/faculty/]   For more medical education from Wiley, please visit https://focus.wiley.com/ [https://focus.wiley.com/]

Part 5: Early Recognition and Intervention in Cancer Cachexia

Welcome to the first part of our Cancer Cachexia ASCO 2025 Highlights. Cancer cachexia is a progressive muscle-wasting syndrome that significantly diminishes the quality of life for many patients with cancer. For this episode we are joined by Associate Professor Richard Dunne who will be sharing his highlights from ASCO 2025, specifically addressing the latest research concerning cancer cachexia, its progression, methods for clinically scoring and staging the condition, including novel approaches and factors associated with its incidents.  This discussion was originally broadcast as a Conference Highlights Video, published as part of the American Cancer Society - Cancer Cachexia Knowledge Hub educational program. To view the original video please visit https://cancercachexia.knowledgehub.wiley.com/conference-coverage/asco-2025-highlights/ [https://cancercachexia.knowledgehub.wiley.com/conference-coverage/asco-2025-highlights/]. The Knowledge Hub also contains additional educational materials on cancer cachexia, including two ACCME accredited webinar broadcasts, conference highlights from AACR 2025, ASCO 2025, ASCO GI 2026, ESMO 2025, SCWD 2024 and 2025 as well as additional resources such as research article collections and downloadable infographics.  The Cancer Cachexia Knowledge Hub program is supported by an educational grant from Pfizer.  Speaker – Dr Richard Dunne. Associate Professor of Medicine & Section Leader, GI Oncology, Wilmot Cancer Institute and The University of Rochester Medical Center. Full speaker biography - https://cancercachexia.knowledgehub.wiley.com/faculty/ [https://cancercachexia.knowledgehub.wiley.com/faculty/]   For more medical education from Wiley, please visit https://focus.wiley.com/ [https://focus.wiley.com/]

Part 4: Early Recognition and Intervention in Cancer Cachexia

Welcome to our first Patient Case Study on cancer cachexia. Cancer cachexia is a progressive muscle-wasting syndrome that significantly diminishes the quality of life for many patients with cancer. For this episode we are joined by Associate Professor Richard Dunne who will be discussing the case study of a patient with cancer cachexia, offering insights into the medical management of involuntary weight loss. The case study also explores challenges and strategies in ensuring mental health support, physical activity, and nutritional care for patients with cancer cachexia.  This discussion was originally broadcast as a Video Clinical Case Study, published as part of the American Cancer Society - Cancer Cachexia Knowledge Hub educational program. To view the original video please visit https://cancercachexia.knowledgehub.wiley.com/case-studies/ [https://cancercachexia.knowledgehub.wiley.com/case-studies/]. The Knowledge Hub also contains additional educational materials on cancer cachexia, including two ACCME accredited webinar broadcasts, conference highlights from AACR 2025, ASCO 2025, ASCO GI 2026, ESMO 2025, SCWD 2024 and 2025 as well as additional resources such as research article collections and downloadable infographics.  The Cancer Cachexia Knowledge Hub program is supported by an educational grant from Pfizer.  Speaker – Dr Richard Dunne. Associate Professor of Medicine & Section Leader, GI Oncology, Wilmot Cancer Institute and The University of Rochester Medical Center. Full speaker biography - https://cancercachexia.knowledgehub.wiley.com/faculty/ [https://cancercachexia.knowledgehub.wiley.com/faculty/]   For more medical education from Wiley, please visit https://focus.wiley.com/ [https://focus.wiley.com/]

Part 3: Early Recognition and Intervention in Cancer Cachexia

Welcome to part three of a three-part episode entitled, Early Recognition and Intervention in Cancer Cachexia. Cancer cachexia is a progressive muscle-wasting syndrome that significantly diminishes the quality of life for many patients with cancer. For part three, we are joined by Professors Aminah Jatoi, Jeffrey Crawford, and Dr Rony Dev for a panel discussion on proactive detection and management strategies.  This discussion was originally broadcast as an ACCME-accredited webinar entitled, Early Recognition and Intervention in Cancer Cachexia: Pathophysiology, Diagnosis, and Management, delivered by Professor Aminah Jatoi, Professor Jeffrey Crawford and Dr Rony Dev. It was published as part of the American Cancer Society - Cancer Cachexia Knowledge Hub educational program. To claim 1.0 AMA PRA Category 1TM credit for this episode, along with parts two and three, please visit https://cancercachexia.knowledgehub.wiley.com/webinars/early-recognition-and-intervention-in-cancer-cachexia/ [https://cancercachexia.knowledgehub.wiley.com/webinars/early-recognition-and-intervention-in-cancer-cachexia/]. The Knowledge Hub also contains additional educational materials on cancer cachexia, including conference highlights from AACR 2025, ASCO 2025, ASCO GI 2026, ESMO 2025, SCWD 2024 and 2025 as well as additional resources such as practical case studies and downloadable infographics.  The Cancer Cachexia Knowledge Hub program is supported by an educational grant from Pfizer.  Speaker - Professor Aminah Jatoi, MD. Betty J. Foust, MD and Parents' Professor of Oncology, Mayo Clinic, Rochester, Minnesota. Full speaker biography - https://cancercachexia.knowledgehub.wiley.com/faculty/ [https://cancercachexia.knowledgehub.wiley.com/faculty/]   Speaker - Professor Jeffrey Crawford, MD. George Barth Galler Professor for Research in Cancer, Department of Medicine, Duke University Medical Center. Full speaker biography - https://cancercachexia.knowledgehub.wiley.com/faculty/ [https://cancercachexia.knowledgehub.wiley.com/faculty/]  Speaker - Dr. Rony Dev. Associate Professor, Department of Palliative Care and Rehabilitation Medicine, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas. Full speaker biography - https://cancercachexia.knowledgehub.wiley.com/faculty/ [https://cancercachexia.knowledgehub.wiley.com/faculty/]  For more medical education from Wiley, please visit https://focus.wiley.com/ [https://focus.wiley.com/]